Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Urethane anesthesia in rats. Altered ability to regulate hydration

W B Severs, L C Keil, P A Klase

    Pharmacology
    |January 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    IL8 polymorphisms and overall survival in pazopanib- or sunitinib-treated patients with renal cell carcinoma.

    British journal of cancer·2015
    Same author

    Hyperbilirubinemia in pazopanib- or sunitinib-treated patients in COMPARZ is associated with UGT1A1 polymorphisms.

    Annals of oncology : official journal of the European Society for Medical Oncology·2013
    Same author

    Consummatory behavior and metabolic indicators after central ghrelin injections in rats.

    Regulatory peptides·2008
    Same author

    The effect of centrally administered ghrelin on pituitary ACTH cells and circulating ACTH and corticosterone in rats.

    Life sciences·2006
    Same author

    Central effects of ghrelin on serum growth hormone and morphology of pituitary somatotropes in rats.

    Experimental biology and medicine (Maywood, N.J.)·2006
    Same author

    Somatostatin-14 alters the thymus size and relation among the thymocyte subpopulations in peripubertal rats.

    Neuropeptides·2004

    Intraperitoneal urethane anesthesia in rats causes fluid accumulation and impaired kidney function, likely due to mesenteric vascular osmotoxicity. Intravenous urethane avoids these issues, suggesting route-dependent effects on rat physiology.

    Area of Science:

    • Physiology
    • Pharmacology
    • Toxicology

    Background:

    • Urethane is a common anesthetic agent used in rodent research.
    • The route of administration can significantly impact drug pharmacokinetics and physiological effects.
    • Understanding anesthetic side effects is crucial for accurate experimental data interpretation.

    Purpose of the Study:

    • To investigate the physiological consequences of intraperitoneal urethane anesthesia in rats.
    • To compare the effects of intraperitoneal versus intravenous urethane administration on renal function and fluid balance.
    • To identify the mechanisms underlying the observed physiological alterations.

    Main Methods:

    • Administration of urethane via intraperitoneal and intravenous routes in rats.

    Related Experiment Videos

  • Monitoring of peritoneal fluid accumulation, renal response to fluid/salt loading, and plasma osmolality.
  • Assessment of potential contributing factors including hormones and renal nerves.
  • Main Results:

    • Intraperitoneal urethane caused peritoneal fluid accumulation, impaired renal response to loading, and hyperosmolality without affecting plasma sodium.
    • These effects were not attributed to anesthesia per se, angiotensin, aldosterone, vasopressin, or renal nerves.
    • Intravenous urethane induced osmotic diuresis without peritoneal fluid leakage, despite increased plasma osmolality.
    • Mesenteric vasculature osmotoxicity was identified as a probable cause for intraperitoneal urethane's effects.

    Conclusions:

    • Intraperitoneal urethane anesthesia significantly disrupts fluid balance and renal function in rats.
    • The route of urethane administration critically influences its physiological impact, with intravenous administration being less disruptive to fluid homeostasis.
    • Findings highlight the potential for intraperitoneal urethane to confound experimental results due to osmotoxicity and altered body fluid composition.